Loading company…
SSI Diagnostica makes in vitro diagnostic products, mainly for microbiological laboratories and healthcare institutions.
SSI Diagnostica A/S develops in vitro diagnostic tests and reagents for infectious diseases, sold to microbiological laboratories and healthcare institutions in nearly 100 countries. Founded in 1902 in Denmark and based in Copenhagen, the company is at the Series B stage. It moved from Adelis Equity Partners I to SSID CV Fund in August 2022, and its recent DKK 250.000 mn Public to Private round is intended to fund the acquisition of TechLab, Inc.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in